Gene · 10288
Papers2,402
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,402
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Revisiting HLA-G in solid organ transplantation: Mechanistic insights and translational advances. | Hum Immunol | 2026 | 41724096 | PubTator, text mining | PubMed |
| Biomarkers and advances in AML-MRC: from bench to bedside. | Ann Hematol | 2026 | 41711916 | PubTator, text mining | PubMed |
| Ethnic-specific effects of the LILRB2-LILRB5 locus and newly identified risk loci for Alzheimer's disease in the East Asian population. | Alzheimers Dement | 2026 | 41700061 | PubTator, text mining | PubMed |
| Human Leukocyte Antigen (HLA) and Tumor Immunity: A Critical Link in Cancer Immunotherapy. | Immun Inflamm Dis | 2026 | 41699399 | PubTator, text mining | PubMed |
| Unlocking the promise of innate biology through the HLA-G/ILT2/ILT4 pathway. | J Immunother Cancer | 2026 | 41692513 | PubTator, text mining | PubMed |
| Neoadjuvant chemoimmunotherapy in non-small cell lung cancer: evolving resectability criteria, biomarker-driven postoperative management, and emerging therapeutic strategies. | J Immunother Cancer | 2026 | 41638870 | PubTator, text mining | PubMed |
| Comprehensive profiling of the human tear fluid miRNome using small RNA sequencing. | Ocul Surf | 2026 | 41638553 | PubTator, text mining | PubMed |
| Resilience of human tolerogenic dendritic cells to physiological oxygen supports clinical application: functional stability amidst glycolytic and differentiation shifts. | Exp Hematol Oncol | 2026 | 41572330 | PubTator, text mining | PubMed |
| ILT4 and its R20H variant as marker of poor prognosis in Spanish patients with colorectal cancer. | Hum Immunol | 2026 | 41570702 | PubTator, text mining | PubMed |
| The making of multispecific immunoglobulins - a clinical perspective. | MAbs | 2026 | 41542910 | PubTator, text mining | PubMed |
| A Subset of Pro-inflammatory CXCL10+ LILRB2+ Macrophages Derives From Recipient Monocytes and Drives Renal Allograft Rejection. | Adv Sci (Weinh) | 2026 | 41517835 | PubTator, text mining | PubMed |
| Integrative analysis of single-cell and bulk RNA sequencing data for discovery of senescent TAMs prognostic characteristics in neuroblastoma. | BMC Cancer | 2026 | 41491450 | PubTator, text mining | PubMed |
| Study of the association of LILRB2 gene polymorphisms with colorectal cancer susceptibility and prognosis in Tunisian population. | Hum Immunol | 2026 | 41418557 | PubTator, text mining | PubMed |
| Microglial phagocytosis in Alzheimer disease. | Nat Rev Neurol | 2026 | 41315858 | PubTator, text mining | PubMed |
| Macrophage-centered therapy strategies: A promising weapon in cancer immunotherapy. | Asian J Pharm Sci | 2025 | 41809255 | PubTator, text mining | PubMed |
| Identification and validation of HOXB3 hypomethylation as a novel prognostically epigenetic biomarker in acute myeloid leukemia. | Front Immunol | 2025 | 41601621 | PubTator, text mining | PubMed |
| Relationship between LILRB2 and APE1 levels and pathological characteristics in colorectal cancer patients and their predictive value for prognosis. | Front Cell Infect Microbiol | 2025 | 41383852 | PubTator, text mining | PubMed |
| Uncovering mirnomes of patients with interstitial lung diseases and an underlying autoimmune process. | Respir Res | 2025 | 41350880 | PubTator, text mining | PubMed |
| HLA-G regulation through trogocytosis: intercellular membrane transfer mechanisms and immune dysregulation in Systemic Lupus Erythematosus. | Front Cell Dev Biol | 2025 | 41311648 | PubTator, text mining | PubMed |
| Integrative Bioinformatics Analysis Reveals Key Regulatory Genes and Therapeutic Targets in Ulcerative Colitis Pathogenesis. | Genes (Basel) | 2025 | 41300749 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10288/papers?page=2